For 20 years, federal health and justice officials have concocted and applied a warped set of legal principles which essentially prohibit medical product makers from sharing truthful information (even peer-reviewed journal articles) with doctors about off-label uses.
In addition to 120 peer-reviewed scientific articles, I have written a scholarly book that examines how weak and inconsistent findings on potential health hazards tend to get a lot of attention and to be propagated by the media and by attention-seeking activists, like Leszczynski.
Since coming to the Hoover Institution, I have become well known for both contributions to peer-reviewed scholarly journals and for articles and books that make science, medicine, and technology accessible to non-experts.
One provision restricts the ability of drug makers to use sales and marketing personnel to distribute peer reviewed reprints of journal articles that contain off-label information.